Karyopharm Therapeutics
KPTI
#8602
Rank
NZ$0.16 B
Marketcap
$1.34
Share price
14.66%
Change (1 day)
-34.08%
Change (1 year)

EPS for Karyopharm Therapeutics (KPTI)

EPS in 2023 (TTM): -$2.13

According to Karyopharm Therapeutics 's latest financial reports the company's current EPS (TTM) is -$2.13. In 2022 the company made an earnings per share (EPS) of -$3.28 a decrease over its 2021 EPS that were of -$2.68.

EPS history for Karyopharm Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.13-35.1%
2022-$3.2822.29%
2021-$2.68-39.19%
2020-$4.41-15.48%
2019-$5.223.19%
2018-$5.0611.79%
2017-$4.53-4.44%
2016-$4.74-11.75%
2015-$5.3737.76%
2014-$3.90-74.5%
2013-$15.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.94-238.01%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.42-400.76%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.80-325.17%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.46-121.46%๐Ÿ‡บ๐Ÿ‡ธ USA